Unusual Peripheral Neuropathies. Part I: Extrinsic Causes

 

 Buy Article Permissions and Reprints

ABSTRACT

Peripheral neuropathy is common with many different etiologies. This is the first of three articles reviewing the less common causes of peripheral neuropathy. The first article includes the extrinsic causes of neuropathy including toxic/medications, infectious, nutritional, and systemic metabolic derangements. The second and third articles review the intrinsic causes of peripheral neuropathy. These reviews describe common presentations and constellation of manifestations and clinical findings.

REFERENCES

• 1 Baldereschi M, Inzitari M, Di Carlo A, Farchi G, Scafato E, Inzitari D. ILSA Working Group . Epidemiology of distal symmetrical neuropathies in the Italian elderly.  Neurology. 2007;  68(18) 1460-1467
  CrossrefPubMedGoogle Scholar
• 2 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis.  Ann Neurol. 1981;  10(3) 222-226
  CrossrefPubMedGoogle Scholar
• 3 Lubec D, Müllbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases.  Postgrad Med J. 1999;  75(890) 723-727
  CrossrefPubMedGoogle Scholar
• 4 Smith A G, Singleton J R. The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy.  Arch Intern Med. 2004;  164(9) 1021-1025
  CrossrefPubMedGoogle Scholar
• 5 Martyn C N, Hughes R A. Epidemiology of peripheral neuropathy.  J Neurol Neurosurg Psychiatry. 1997;  62(4) 310-318
  CrossrefPubMedGoogle Scholar
• 6 Emery A E. Population frequencies of inherited neuromuscular diseases—a world survey.  Neuromuscul Disord. 1991;  1(1) 19-29
  CrossrefPubMedGoogle Scholar
• 7 Mold J W, Vesely S K, Keyl B A, Schenk J B, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients.  J Am Board Fam Pract. 2004;  17(5) 309-318
  CrossrefPubMedGoogle Scholar
• 8 Aronson J K, Dukes M NG. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 15th ed. Amsterdam/Boston; Elsevier 2006
  Google Scholar
• 9 Davies D M. Textbook of Adverse Drug Reactions. 4th ed. Oxford/New York; Oxford University Press 1991: xiv, 879
  Google Scholar
• 10 PDR Guide to Drug Interactions, Side Effects, and Indications. Montvale, NJ; Thomson PDR 2006: v
  Google Scholar
• 11 Argov Z, Mastaglia F L. Drug-induced peripheral neuropathies.  BMJ. 1979;  1(6164) 663-666
  CrossrefPubMedGoogle Scholar
• 12 Charness M E, Morady F, Scheinman M M. Frequent neurologic toxicity associated with amiodarone therapy.  Neurology. 1984;  34(5) 669-671
  CrossrefPubMedGoogle Scholar
• 13 Kuncl R W, Cornblath D R, Avila O, Duncan G. Electrodiagnosis of human colchicine myoneuropathy.  Muscle Nerve. 1989;  12(5) 360-364
  CrossrefPubMedGoogle Scholar
• 14 Simpson D M. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy.  J Neurovirol. 2002;  8(Suppl 2) 33-41
  CrossrefPubMedGoogle Scholar
• 15 Holmberg L, Boman G, Böttiger L E, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports.  Am J Med. 1980;  69(5) 733-738
  CrossrefPubMedGoogle Scholar
• 16 Schaumburg H, Kaplan J, Windebank A et al.. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.  N Engl J Med. 1983;  309(8) 445-448
  CrossrefPubMedGoogle Scholar
• 17 Phan T, McLeod J G, Pollard J D, Peiris O, Rohan A, Halpern J P. Peripheral neuropathy associated with simvastatin.  J Neurol Neurosurg Psychiatry. 1995;  58(5) 625-628
  CrossrefPubMedGoogle Scholar
• 18 Chong P H, Boskovich A, Stevkovic N, Bartt R E. Statin-associated peripheral neuropathy: review of the literature.  Pharmacotherapy. 2004;  24(9) 1194-1203
  CrossrefPubMedGoogle Scholar
• 19 Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.  Eur J Cancer. 2008;  44(11) 1507-1515
  CrossrefPubMedGoogle Scholar
• 20 London Z, Albers J W. Toxic neuropathies associated with pharmaceutic and industrial agents.  Neurol Clin. 2007;  25(1) 257-276
  CrossrefPubMedGoogle Scholar
• 21 Siegal T, Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps.  Cancer. 1990;  66(6) 1117-1123
  CrossrefPubMedGoogle Scholar
• 22 Koike H, Iijima M, Sugiura M et al.. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.  Ann Neurol. 2003;  54(1) 19-29
  CrossrefPubMedGoogle Scholar
• 23 Kuwabara S, Kai M R, Nagase H, Hattori T. n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features.  Eur Neurol. 1999;  41(3) 163-167
  CrossrefPubMedGoogle Scholar
• 24 Chang Y C. Patients with n-hexane induced polyneuropathy: a clinical follow up.  Br J Ind Med. 1990;  47(7) 485-489
  PubMedGoogle Scholar
• 25 Smith A G, Albers J W. n-Hexane neuropathy due to rubber cement sniffing.  Muscle Nerve. 1997;  20(11) 1445-1450
  CrossrefPubMedGoogle Scholar
• 26 Schaumburg H H, Spencer P S. Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study.  Brain. 1976;  99(2) 183-192
  CrossrefPubMedGoogle Scholar
• 27 Jones H B, Cavanagh J B. Distortions of the nodes of Ranvier from axonal distension by filamentous masses in hexacarbon intoxication.  J Neurocytol. 1983;  12(3) 439-458
  CrossrefPubMedGoogle Scholar
• 28 Kumar N. Neurologic presentations of nutritional deficiencies.  Neurol Clin. 2010;  28(1) 107-170
  CrossrefPubMedGoogle Scholar
• 29 Berger J R. The neurological complications of bariatric surgery.  Arch Neurol. 2004;  61(8) 1185-1189
  CrossrefPubMedGoogle Scholar
• 30 Skeen M B. Neurologic manifestations of gastrointestinal disease.  Neurol Clin. 2002;  20(1) 195-225, vii vii
  CrossrefPubMedGoogle Scholar
• 31 Koffman B M, Greenfield L J, Ali I I, Pirzada N A. Neurologic complications after surgery for obesity.  Muscle Nerve. 2006;  33(2) 166-176
  CrossrefPubMedGoogle Scholar
• 32 Juhasz-Pocsine K, Rudnicki S A, Archer R L, Harik S I. Neurologic complications of gastric bypass surgery for morbid obesity.  Neurology. 2007;  68(21) 1843-1850
  CrossrefPubMedGoogle Scholar
• 33 Green R, Kinsella L J. Current concepts in the diagnosis of cobalamin deficiency.  Neurology. 1995;  45(8) 1435-1440
  CrossrefPubMedGoogle Scholar
• 34 Kinsella L J, Green R. ‘Anesthesia paresthetica’: nitrous oxide-induced cobalamin deficiency.  Neurology. 1995;  45(8) 1608-1610
  CrossrefPubMedGoogle Scholar
• 35 Amaral J F, Thompson W R, Caldwell M D, Martin H F, Randall H T. Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity.  Ann Surg. 1985;  201(2) 186-193
  PubMedGoogle Scholar
• 36 Saperstein D S, Wolfe G I, Gronseth G S et al.. Challenges in the identification of cobalamin-deficiency polyneuropathy.  Arch Neurol. 2003;  60(9) 1296-1301
  CrossrefPubMedGoogle Scholar
• 37 Ohnishi A, Tsuji S, Igisu H et al.. Beriberi neuropathy. Morphometric study of sural nerve.  J Neurol Sci. 1980;  45(2-3) 177-190
  CrossrefPubMedGoogle Scholar
• 38 Kumar N, Boes C J, Vilensky J. Neurologic sequelae of deficiency diseases in World War II prisoners of war: extracts from a videographic narrative.  J Clin Neurosci. 2010;  17(3) 294-295
  CrossrefPubMedGoogle Scholar
• 39 Henri-Bhargava A, Melmed C, Glikstein R, Schipper H M. Neurologic impairment due to vitamin E and copper deficiencies in celiac disease.  Neurology. 2008;  71(11) 860-861
  CrossrefPubMedGoogle Scholar
• 40 Kumar N, Low P A. Myeloneuropathy and anemia due to copper malabsorption.  J Neurol. 2004;  251(6) 747-749
  PubMedGoogle Scholar
• 41 Goodman B P, Bosch E P, Ross M A, Hoffman-Snyder C, Dodick D D, Smith B E. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy.  J Neurol Neurosurg Psychiatry. 2009;  80(5) 524-527
  CrossrefPubMedGoogle Scholar
• 42 Weihl C C, Lopate G. Motor neuron disease associated with copper deficiency.  Muscle Nerve. 2006;  34(6) 789-793
  CrossrefPubMedGoogle Scholar
• 43 Nations S P, Boyer P J, Love L A et al.. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.  Neurology. 2008;  71(9) 639-643
  CrossrefPubMedGoogle Scholar
• 44 Rosenbaum R. Neuromuscular complications of connective tissue diseases.  Muscle Nerve. 2001;  24(2) 154-169
  CrossrefPubMedGoogle Scholar
• 45 Said G. Infectious neuropathies.  Neurol Clin. 2007;  25(1) 115-137
  CrossrefPubMedGoogle Scholar
• 46 Soysal A, Atay T, Ozu T, Arpaci B. Electrophysiological evaluation of peripheral and autonomic involvement in leprosy.  Can J Neurol Sci. 2004;  31(3) 357-362
  PubMedGoogle Scholar
• 47 Marques Jr W, Foss N T, Arruda A P, Barreira A A. Near-nerve potential in lepromatous leprosy.  Muscle Nerve. 2003;  28(4) 460-463
  CrossrefPubMedGoogle Scholar
• 48 Mygland A, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease.  Eur J Neurol. 2006;  13(11) 1213-1215
  CrossrefPubMedGoogle Scholar
• 49 Ferrari S, Vento S, Monaco S et al.. Human immunodeficiency virus-associated peripheral neuropathies.  Mayo Clin Proc. 2006;  81(2) 213-219
  CrossrefPubMedGoogle Scholar
• 50 Ellis R J, Rosario D, Clifford D B CHARTER Study Group et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.  Arch Neurol. 2010;  67(5) 552-558
  CrossrefPubMedGoogle Scholar
• 51 Alpa M, Ferrero B, Cavallo R et al.. Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia.  Autoimmun Rev. 2008;  8(1) 56-58
  CrossrefPubMedGoogle Scholar
• 52 Feibel J H, Campa J F. Thyrotoxic neuropathy (Basedow's paraplegia).  J Neurol Neurosurg Psychiatry. 1976;  39(5) 491-497
  CrossrefPubMedGoogle Scholar
• 53 Torres C F, Moxley R T. Hypothyroid neuropathy and myopathy: clinical and electrodiagnostic longitudinal findings.  J Neurol. 1990;  237(4) 271-274
  CrossrefPubMedGoogle Scholar
• 54 Ørstavik K, Norheim I, Jørum E. Pain and small-fiber neuropathy in patients with hypothyroidism.  Neurology. 2006;  67(5) 786-791
  CrossrefPubMedGoogle Scholar
• 55 McManis P G, Windebank A J, Kiziltan M. Neuropathy associated with hyperlipidemia.  Neurology. 1994;  44(11) 2185-2186
  PubMedGoogle Scholar
• 56 Delaney P. Gouty neuropathy.  Arch Neurol. 1983;  40(13) 823-824
  PubMedGoogle Scholar

Matthew GrantzM.D. 

Department of Neurology, University of Utah

175 North Medical Drive, Salt Lake City, UT 84132

Email: Matthew.Grantz@hsc.utah.edu